Cysto-Conray II (Liebel-Flarsheim Company LLC)


Welcome to the PulseAid listing for the Cysto-Conray II drug offered from Liebel-Flarsheim Company LLC. This Radiographic Contrast Agent [EPC],X-Ray Contrast Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Liebel-Flarsheim Company LLC
NON-PROPRIETARY NAME: Iothalamate meglumine
SUBSTANCE NAME: IOTHALAMATE MEGLUMINE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Radiographic Contrast Agent [EPC],X-Ray Contrast Activity [MoA]
ROUTE: URETERAL
DOSAGE FORM: INJECTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2010-10-08
END MARKETING DATE: 0000-00-00


Cysto-Conray II HUMAN PRESCRIPTION DRUG Details:

Item DescriptionCysto-Conray II from Liebel-Flarsheim Company LLC
LABELER NAME: Liebel-Flarsheim Company LLC
DEA SCHEDULE:
ACTIVE STRENGTH: 172(mg/mL)
START MARKETING DATE: 2010-10-08
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0019-0862_dd585c37-4a03-4158-9217-40a8ca4544db
PRODUCT NDC: 0019-0862
APPLICATION NUMBER: NDA017057

Other IOTHALAMATE MEGLUMINE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Liebel-Flarsheim Company LLCCysto-Conray II